Logo-bi
Review

1. Nanocapsules: the weapons for novel drug delivery systems.
Pavankumar Kothamasu*, Hemanth Kanumur, Niranjan Ravur, Chiranjeevi Maddu, Radhika Parasuramrajam, Sivakumar Thangavel
Bioimpacts. 2012;2(2): 71-81. doi: 10.5681/bi.2012.011
PMCID: PMC3648923     PMID: 23678444     Scopus ID: 84876742237    
Article
PDF
XML
Cited By:
165
31
0
Review

2. Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumors
Marziyeh Fathi, Jaleh Barar* ORCID
Bioimpacts. 2017;7(1): 49-57. doi: 10.15171/bi.2017.07
PMCID: PMC5439389     PMID: 28546953     Scopus ID: 85019106716    
Article
PDF
Full Text
XML
Cited By:
38
10
34
Review

3. Stimuli-responsive chitosan-based nanocarriers for cancer therapy
Marziyeh Fathi, Parham Sahandi Zangabad, Sima Majidi, Jaleh Barar, Hamid Erfan-Niya, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(4): 269-277. doi: 10.15171/bi.2017.32
PMCID: PMC5801539     PMID: 29435435     Scopus ID: 85041008382    
Article
PDF
Full Text
XML
Cited By:
67
11
61
Editorial

4. Aptamedicine: a new treatment modality in personalized cancer therapy
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(2): 67-70. doi: 10.15171/bi.2019.09
PMCID: PMC6637218     PMID: 31334037     Scopus ID: 85067455587    
Article
PDF
Full Text
XML
Cited By:
14
2
2
Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.
Editorial

5. Therapeutic impacts of enzyme-responsive smart nanobiosystems
Marziyeh Fathi ORCID, Azam Safary ORCID, Jaleh Barar* ORCID
Bioimpacts. 2020;10(1): 1-4. doi: 10.15171/bi.2020.01
PMCID: PMC6977590     PMID: 31988850     Scopus ID: 85078980716    
Article
PDF
Full Text
XML
Cited By:
16
0
13
Jaleh Barar (PharmD, PhD) is Professor of Drug Delivery and Targeting. She currently is the chair of the department of Pharmaceutics at the Faculty of Pharmacy, Tabriz university of Medical Sciences. Professor Barar’s research is focused on various aspects of the pharmaceutical cell biology with the particular emphasis on the development of novel drug delivery and targeting strategies to combat cancer.

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge